Charlesson's News

12/1/2009:

Some eye disease can be halted, Oklahoma researcher says

11/20/2009:

Charlesson scientist, Dr. Danyang Chen, received word that he had been selected to receive a two year OARS grant totaling $250,548 from the Oklahoma Center for the Advancement of Science and Technology (OCAST)

10/27/2009:

Charlesson featured at Bricktown Capital Conference

10/7/2009:

Charlesson selected as a Finalist for the 2009 Oklahoma Business Roundtable Venture of the Year Award

09/16/2009:

Metro 50 ranks Charlesson as the 8th fastest growing company in the Oklahoma City metro area.

08/19/2009:

Inc. 500 Ranks Charlesson as One of America's Fastest Growing Private Companies

07/1/2009:

Charlesson co-founder, Dr. Jian-Xing Ma, along with other experts from the Harold Hamm Diabetes Center, speak about their recent discoveries in the area of diabetic retinopathy.

06/30/2009:

Charlesson scientist, Dr. Rafal Farjo, received word that he had been selected to receive a NIH phase I grant totaling $227,286 from the National Institutes of Health to develop CLT-010 for the treatment of Diabetic Retinopathy.

06/25/2009:

Charlesson to present at Life Sciences Venture Forum in San Jose, CA

06/24/2009:

Charlesson scientist, Dr. Rafal Farjo, received word that he had been selected to receive a two year OARS grant totaling $227,286 from the Oklahoma Center for the Advancement of Science and Technology (OCAST)

05/26/2009:

Oklahoma company gets a warm reception at the 2009 International BIO Convention

05/25/2009:

Charlesson discusses the company’s business model, which sees its in-house activities benefit from revenues, experience and contacts generated by its preclinical service offering

04/28/2009:

Charlesson announces upcoming presentations at the 2009 annual meeting of the Association for Research in Vision and Ophthalmology (ARVO).

04/13/2009:

Charlesson scientist, Dr. Danyang Chen, receives a $248,094 Phase I SBIR grant from the National Institutes of Health to develop CLT-010 for the treatment of Diabetic Retinopathy.

02/04/2009:

Oklahoma-based Charlesson LLC funding totals more than $10 million